These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10170706)

  • 21. Cost effectiveness of vaccination against pneumococcal pneumonia.
    Willems JS; Sanders CR; Riddiough MA; Bell JC
    N Engl J Med; 1980 Sep; 303(10):553-9. PubMed ID: 6772950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consumer information and biased selection in the demand for coverage supplementing Medicare.
    Davidson BN; Sofaer S; Gertler P
    Soc Sci Med; 1992 May; 34(9):1023-34. PubMed ID: 1631602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moral hazard.
    Stone D
    J Health Polit Policy Law; 2011 Oct; 36(5):887-96. PubMed ID: 21785008
    [No Abstract]   [Full Text] [Related]  

  • 24. Budget crisis, entitlement crisis, health care financing problem--which is it?
    Aaron HJ
    Health Aff (Millwood); 2007; 26(6):1622-33. PubMed ID: 17978382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse selection, moral hazard, and wealth effects in the Medigap insurance market.
    Wolfe JR; Goddeeris JH
    J Health Econ; 1991; 10(4):433-59. PubMed ID: 10117013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Worker demand for health insurance in the non-group market: a note on the calculation of welfare loss.
    Chernew M; Frick K; McLaughlin CG
    J Health Econ; 1997 Jun; 16(3):375-80. PubMed ID: 10169307
    [No Abstract]   [Full Text] [Related]  

  • 27. Digital Breast Tomosynthesis: Cost-Effectiveness of Using Private and Medicare Insurance in Community-Based Health Care Facilities.
    Hunter SA; Morris C; Nelson K; Snyder BJ; Poulton TB
    AJR Am J Roentgenol; 2017 May; 208(5):1171-1175. PubMed ID: 28177646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Family income and the impact of a children's health insurance program on reported need for health services and unmet health need.
    Feinberg E; Swartz K; Zaslavsky A; Gardner J; Walker DK
    Pediatrics; 2002 Feb; 109(2):E29. PubMed ID: 11826239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating welfare losses in the health care market.
    Peele PB
    J Health Econ; 1993 Jul; 12(2):205-8. PubMed ID: 10127779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicare and cost-effectiveness analysis.
    Neumann PJ; Rosen AB; Weinstein MC
    N Engl J Med; 2005 Oct; 353(14):1516-22. PubMed ID: 16207857
    [No Abstract]   [Full Text] [Related]  

  • 31. Attrition in the RAND Health Insurance Experiment: a response to Nyman.
    Newhouse JP; Brook RH; Duan N; Keeler EB; Leibowitz A; Manning WG; Marquis MS; Morris CN; Phelps CE; Rolph JE
    J Health Polit Policy Law; 2008 Apr; 33(2):295-308; discussion 309-17. PubMed ID: 18325902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health insurance coverage among the elderly.
    Wilcox-Gök V; Rubin J
    Soc Sci Med; 1994 Jun; 38(11):1521-9. PubMed ID: 8036532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uncertainty and the welfare economics of medical care. 1963.
    Arrow KJ
    J Health Polit Policy Law; 2001 Oct; 26(5):851-83. PubMed ID: 11765268
    [No Abstract]   [Full Text] [Related]  

  • 34. Optimal quality, waits and charges in health insurance.
    Gravelle H; Siciliani L
    J Health Econ; 2008 May; 27(3):663-74. PubMed ID: 18191254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Critical Analysis of Obamacare: Affordable Care or Insurance for Many and Coverage for Few?
    Manchikanti L; Helm Ii S; Benyamin RM; Hirsch JA
    Pain Physician; 2017 Mar; 20(3):111-138. PubMed ID: 28339427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing advanced illness: a quality and cost challenge to Medicare, Medicaid, and private insurers.
    Matherlee K
    NHPF Issue Brief; 2002 Jun; (779):1-19. PubMed ID: 12096766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new Medicare drug benefit: much ado about little?
    Pauly MV
    LDI Issue Brief; 2004; 9(4):1-6. PubMed ID: 15035261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymmetric Information in Iranian's Health Insurance Market: Testing of Adverse Selection and Moral Hazard.
    Lotfi F; Abolghasem Gorji H; Mahdavi G; Hadian M
    Glob J Health Sci; 2015 Apr; 7(6):146-55. PubMed ID: 26153155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opacity and cost effectiveness analysis in Medicare coverage decisions: health policy encounters administrative law.
    Kolber MS
    Food Drug Law J; 2009; 64(3):515-30. PubMed ID: 19999645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reflections on the reflections.
    Arrow KJ
    J Health Polit Policy Law; 2001 Oct; 26(5):1197-203. PubMed ID: 11765265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.